MisakoNagasakaMDPhD

Oncology • Orange, CA

Thoracic Cancer

Associate Clinical Professor

Join to view full profile

Dr. Nagasaka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nagasaka's full profile

Already have an account?

Office
101 The City Dr S
Orange, CA 92868
Phone+1 714-456-8000

Fax+1 714-456-2242

Education & Training

Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2014 - 2017
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2011 - 2014

Certifications & Licensure

HI State Medical License 2021 - 2026
CA State Medical License 2021 - 2025
MI State Medical License 2017 - 2024
SC State Medical License 2013 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Home Sleep Apnea Machine in Evaluating Obstructive Sleep Apnea in Patients With Stage III-IV Head and Neck Cancer Start of enrollment: 2023 Jul 25
Withdrawn
Not Applicable
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC Start of enrollment: 2021 Sep 01
Recruiting
Phase 2
Roles: Contact
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer Start of enrollment: 2023 Jun 01
Not yet recruiting
Phase 1, Phase 2
Roles: Contact

Publications & Presentations

PubMed

The User's Guide to Amivantamab.
Danielle Brazel, Janellen Smith, Sai-Hong Ignatius Ou, Misako Nagasaka
Targeted Oncology. 2025-02-04
Consolidation ALK Tyrosine Kinase Inhibitor in Definitively Treated Unresectable Stage III ALK+ NSCLC: Can Real-World Data Inform Clinical Decision in the Absence of a...
Zhaohui Liao Arter, Sai-Hong Ignatius Ou, Misako Nagasaka
Journal of Thoracic Oncology. 2025-01-01
Real-World Prevalence, Treatment Patterns, and Outcomes for Patients With HER2 (ERBB2)-Mutant Metastatic Non-Small Cell Lung Cancer, From a US-Based Clinico-Genomic Da...
Sarah Waliany, Misako Nagasaka, Leah Park, Clara Lam, Zoe Jiang
Cancer Medicine. 2024-12-01

Press Mentions

AnHeart Therapeutics Announces Publication of Taletrectinib Global Phase 2 Clinical Trial (TRUST-II) Design in Future OncologyMarch 9th, 2023
AnHeart Therapeutics to Present Poster and Host Investigator Meeting at WCLC 2022August 4th, 2022
Dr. Nagasaka Named to National 40 Under 40 in Cancer Class of 2020November 17th, 2020